The New Biopharmaceutical Blueprint: Aligning Business And It With Service-oriented Architecture
- Tags:
- Enterprise Software,
- Middleware,
- Service-Oriented Architecture (SOA),
- SOA,
- Software,
- Web Services
- Source:
- IBM
FREE Registration is required
Overview: Bringing a pharmaceutical or biologic product to market takes more than just good science. It takes an agile business to respond to the changing market dynamics. R&D is under pressure to bring new treatments to market faster and extend its reach in global markets. Likewise, manufacturing needs to incorporate more efficient, quality-centric processes that scale across regions and partners. At the same time, sales and marketing need to address regulatory demands by re-evaluating how they manage the increasing number of channels and partners. The challenges of integrating technologies can hamper all of these efforts. Service-oriented architecture (SOA) can serve as the new blueprint for aligning business and IT. This paper explores how SOA can help enterprises effectively achieve business flexibility within a compliant environment.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 1,311KB | Date: Oct 2007 | Pages: 24
Top results from Strategic Analysis
» View all Strategic Analysis listings






